Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Edaravone and Sodium Chloride Injection

Approval Number

国药准字H20193434

Company江苏正大丰海制药有限公司

Registration Date

December 30, 2019

Drug Information

Generic Name

依达拉奉氯化钠注射液

Dosage Form

注射剂

Strength

100ml:依达拉奉30mg与氯化钠855mg

Drug Type

化学药品

Registration Date

December 30, 2019

Company Information

Applicant Company

Company Name江苏正大丰海制药有限公司

Company Address

江苏省盐城市大丰区南翔西路266号

Manufacturing Company

Company Name江苏正大丰海制药有限公司

Company Address

江苏省盐城市大丰区南翔西路266号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

依达拉奉氯化钠注射液 - NMPA 批准文号 | MedPath